India's biomanufacturing ecosystem may already hold much of the industrial capacity needed to support the next phase of smart protein development, according to a new study that could shape policy and investment thinking in the sector. The report, titled "Mapping India's biomanufacturing potential for smart proteins," identifies 478 facilities across nine biomanufacturing segments in 17 states and estimates that the country has about 198 million kilolitres of smart protein-relevant fermenter capacity.
Capacity Advantage
The findings matter because smart proteins — a category that includes alternative proteins produced through fermentation and other advanced bioprocessing methods — depend heavily on scalable, reliable manufacturing infrastructure. In practical terms, the study suggests India may not need to build the sector from scratch. Instead, it could repurpose or extend existing industrial assets, lowering the capital intensity and time required to bring new products to market.
That is significant for a country seeking to diversify its food and bioeconomy base while also strengthening manufacturing competitiveness. Fermentation capacity is one of the most important bottlenecks in smart protein production, and the report's estimate points to a substantial installed base that could be leveraged if technical, regulatory and commercial conditions align. For investors, the implication is clear: India's opportunity may lie less in greenfield construction and more in upgrading, integrating and de-risking existing facilities.
The study's mapping across 17 states also highlights the geographic breadth of India's biomanufacturing footprint. Rather than being concentrated in a single industrial cluster, the capacity appears distributed across multiple regions, which could support supply-chain resilience and reduce the risk of overdependence on one corridor or state. That dispersion may also create opportunities for state-level industrial policy, especially where governments are seeking to attract higher-value bio-based manufacturing.
Policy And Investment Signal
The report arrives at a time when India is under growing pressure to expand domestic manufacturing in strategic sectors while improving resource efficiency and food-system resilience. Smart proteins have emerged globally as a potential answer to rising demand for protein, climate constraints and supply-chain volatility. In India, the sector has additional relevance because of the country's large consumer base, its deep fermentation and biotech talent pool, and its established presence in pharmaceuticals, enzymes, food processing and industrial biotechnology.
Yet the transition from industrial capacity to commercial smart protein output is not automatic. Facilities may require retrofitting, process validation, quality assurance systems and regulatory clarity before they can serve food-grade or ingredient-grade applications. The report therefore functions less as a declaration of immediate output and more as a strategic map of latent capacity. It suggests the country's challenge is not only to invent new technologies, but to connect existing manufacturing strength with emerging demand.
That distinction is important for fiscal and industrial policy. If policymakers view smart proteins as part of the broader manufacturing and innovation agenda, they could design targeted incentives for facility conversion, pilot-scale production, standards development and research partnerships. Such measures could help bridge the gap between laboratory progress and commercial scale, which has historically slowed the adoption of novel food technologies in many markets.
The study also reinforces India's potential role in the global smart protein supply chain. As multinational food and ingredient companies look to diversify production bases, a country with large fermenter capacity, technical manpower and a growing bioeconomy could become an attractive manufacturing destination. But the window may be time-sensitive. Other markets are also racing to build fermentation infrastructure, and early movers could capture the highest-value segments of the industry.
Scale Without Conversion
Still, the headline number — 198 million kilolitres of relevant fermenter capacity — should be read carefully. Capacity on paper does not necessarily translate into immediately usable smart protein output. The sector will need coordinated action across regulation, standards, financing and market development to turn industrial potential into commercial reality.
Even so, the report provides one of the clearest indications yet that India's biomanufacturing base could be a strategic asset in the smart protein transition. If the country can align policy support with industrial adaptation, it may be able to position itself not just as a consumer market for alternative proteins, but as a production hub with export potential and broader bioeconomic spillovers.
For now, the study offers a compelling message to policymakers and industry alike: India may already possess much of the physical infrastructure needed to scale smart proteins. The next test is whether that capacity can be converted into a competitive manufacturing advantage before the global market matures further.